Prevention of symptomatic seasonal influenza in 2005-2006 by inactivated and live attenuated vaccines
about
Vaccines for preventing influenza in healthy adultsEffectiveness and harms of seasonal and pandemic influenza vaccines in children, adults and elderly: a critical review and re-analysis of 15 meta-analysesThe relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adultsReduced reaction frequencies with repeated inactivated or live-attenuated influenza vaccinationMicrobial Cryptotopes are Prominent Targets of B-cell ImmunityThe Saudi Thoracic Society guidelines for influenza vaccinationsEffectiveness of non-adjuvanted pandemic influenza A vaccines for preventing pandemic influenza acute respiratory illness visits in 4 U.S. communitiesEfficacy and correlates of protection for cell culture-derived and egg-derived inactivated influenza vaccines in younger adults.Influenza Illness and Hospitalizations Averted by Influenza Vaccination in the United States, 2005-2011Influenza vaccines: an Asia-Pacific perspective.Deaths averted by influenza vaccination in the U.S. during the seasons 2005/06 through 2013/14.Intranasal administration of alpha interferon reduces seasonal influenza A virus morbidity in ferretsCurrent status of live attenuated influenza vaccine in the United States for seasonal and pandemic influenza.Evaluation of the attenuation, immunogenicity, and efficacy of a live virus vaccine generated by codon-pair bias de-optimization of the 2009 pandemic H1N1 influenza virus, in ferrets.Seasonal influenza vaccine and protection against pandemic (H1N1) 2009-associated illness among US military personnel.Novel vaccines against influenza viruses.New technologies for influenza vaccines.Challenge of conducting a placebo-controlled randomized efficacy study for influenza vaccine in a season with low attack rate and a mismatched vaccine B strain: a concrete exampleSafety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: a randomized, placebo-controlled trial over two influenza seasons.Incidence of influenza in healthy adults and healthcare workers: a systematic review and meta-analysis.Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP) -- United States, 2014-15 influenza season.Cost-effectiveness analysis of quadrivalent influenza vaccine versus trivalent influenza vaccine for elderly in Hong Kong.Efficacy studies of influenza vaccines: effect of end points used and characteristics of vaccine failures.Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysisInactivated and live, attenuated influenza vaccines protect mice against influenza: Streptococcus pyogenes super-infections.An integrated, multistudy analysis of the safety of Ann Arbor strain live attenuated influenza vaccine in children aged 2-17 years.A cell culture-derived influenza vaccine provides consistent protection against infection and reduces the duration and severity of disease in infected individualsCost-effectiveness of quadrivalent influenza vaccine in Hong Kong - A decision analysis.Benefits of influenza vaccination during pregnancy for pregnant women.Vaccination has minimal impact on the intrahost diversity of H3N2 influenza viruses.Persistence of Antibodies to Influenza Hemagglutinin and Neuraminidase Following One or Two Years of Influenza Vaccination.Randomized comparative study of the serum antihemagglutinin and antineuraminidase antibody responses to six licensed trivalent influenza vaccines.Live, attenuated influenza virus (LAIV) vehicles are strong inducers of immunity toward influenza B virusSeasonal influenza vaccines: evolutions and future trends.Intramuscular immunization with a vesicular stomatitis virus recombinant expressing the influenza hemagglutinin provides post-exposure protection against lethal influenza challenge.The effectiveness of Coxiella burnetii vaccines in occupationally exposed populations: a systematic review and meta-analysis.Assessing vaccine efficacy in influenza clinical trials: challenges and difficulties.Immunologic response to vaccine challenge in pregnant PTPN22 R620W carriers and non-carriers.Comparisons of the Humoral and Cellular Immune Responses Induced by Live Attenuated Influenza Vaccine and Inactivated Influenza Vaccine in AdultsMaternal mortality secondary to acute respiratory failure in Colombia: a population-based analysis.
P2860
Q24197955-59EA766E-E231-4123-AE11-419C909A9784Q24614487-3E62A305-99C0-4C32-B70B-5BEA257861AAQ24622008-D5DD6819-F8DB-405D-A763-5AE1A2D247BBQ24646377-258AC876-BE19-4A89-BC7F-9EFE97A1FADBQ27468862-2B34F350-BB1E-4416-9976-22C4849FF60FQ28394218-01941DF8-6AF8-450D-9C98-AB49FB67F55FQ28741469-E007C6A7-3304-486B-B1BD-91E71E43A6F9Q30226435-75C1AF52-A221-4AEA-89BB-B27709C6B867Q30351995-12C3BF35-F692-4B5E-A15E-CD448FCB2FD3Q30355443-9F464DE1-90FD-4330-AC70-16014228EB78Q30373099-D84C8514-9CF1-4307-8A13-E1C7C192133AQ30374748-FD02007D-223B-4123-BBB0-F1DD12FA2343Q30377205-13E7643D-CAF4-4D5F-854C-6B11A9DFA161Q30382343-BD0FA450-E1DF-41F3-88E2-DB5AE2DBFDA0Q30389669-41CC5A11-7545-434A-98C0-16BD6E23AA3DQ30407716-BA70CD21-027A-4CAB-8C19-543D8A9C250CQ30411859-2B6C47C1-6664-4DD9-9E6B-89A954A4A47FQ30857100-FEE36B77-1F8A-4AFE-875B-0EC9D9CDFBE5Q33541763-CA54FBD7-FC67-4B72-B89F-6B46180C313DQ34058480-8C2E4858-D76A-4783-9CCE-015AAD841A0AQ34433508-44B02F33-2E0C-4C7D-A16B-C89D88BA861CQ34582189-F25F5BCA-CC4F-4EEB-8D95-733825B5553FQ34754945-BE36ED4B-C780-48F5-BFF5-468BA6C4D350Q34783486-AB4DD257-D025-47FD-A63A-F2A5F54C1380Q34885060-AFC9EBD6-0380-422A-BC39-102CCC5DB64EQ35667079-6756AA7E-D09C-4B52-BCE5-F1ADE3B9E73CQ35815281-21895593-C83B-45A5-9331-669D9B69EB27Q35886955-7E0B6C33-23B5-4EBC-A85A-28BE30BD15D2Q36003849-B61A4BA4-ABCC-43C4-84BC-A1DE930DD0C8Q36265115-51BF702B-11EC-4F0B-910D-66ACFBAFC44DQ36306922-29E3093E-9790-43CD-9EF7-E3E1C0776773Q36462309-BD250BFC-9F31-4687-BAD9-3A65E75F63B6Q36900058-BC0F3C30-8152-4CB6-92A7-7ED361B92C8AQ37434517-F9D0C251-4103-471A-8BD9-8591BA07648EQ37455765-83F46A83-070F-4543-8BFE-29BA9CCD2F5FQ38110580-A4D32175-FFB6-4DE2-9C37-15A3CE2C1257Q38127468-C0F437BF-139A-4729-87F0-FAB32765C23AQ38671897-68B1757C-DB73-46A2-85F4-B445765E7078Q40450539-8F563129-72FD-4925-82A9-23CBE68D0AA5Q41585572-A9F17EEA-91FC-44BB-AF44-9666C4282D2A
P2860
Prevention of symptomatic seasonal influenza in 2005-2006 by inactivated and live attenuated vaccines
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prevention of symptomatic seas ...... d and live attenuated vaccines
@en
Prevention of symptomatic seas ...... and live attenuated vaccines.
@nl
type
label
Prevention of symptomatic seas ...... d and live attenuated vaccines
@en
Prevention of symptomatic seas ...... and live attenuated vaccines.
@nl
prefLabel
Prevention of symptomatic seas ...... d and live attenuated vaccines
@en
Prevention of symptomatic seas ...... and live attenuated vaccines.
@nl
P2093
P2860
P356
P1476
Prevention of symptomatic seas ...... d and live attenuated vaccines
@en
P2093
Duane W Newton
Esther R Teich
John C Victor
Judy R Rotthoff
Matthew L Boulton
Rachel K Truscon
Sarah A Campbell
Suzanne E Ohmit
P2860
P304
P356
10.1086/589885
P407
P577
2008-08-01T00:00:00Z